focus -WSS

focus

author：explore 2025-10-02 16:18:54 - browse：193

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Bird flu makes raw milk dangerous to consume, mouse study finds

focus

explore

WSS

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Why hospitals are withdrawing from US News rankings

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Custom gene therapy hints at new path for rare disease treatments

Medicare has a new plan to address drug shortages

Sanders adds drug shortage policies to pandemic preparedness bill

Wikipedia

focus

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

In early work, researchers turn to CRISPR to treat Alzheimer's

Sports medicine is finally prioritizing gender equality

Listen: Wegovy in the brain & pivotal Alzheimer's data

Heart attack and stroke risk calculators need revising

Sanofi seeks simpler, safer CRISPR sickle cell cure

New air purifier tech could be key to improving indoor air quality

New research sheds light on how often breast cancer is overdiagnosed

Virginia high school admissions case could be legal follow

Listen: Wegovy in the brain & pivotal Alzheimer's data

Wikipedia

Google and Epic fight stronger regulation of AI in health care

The Bio Revolution is changing business and society

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

A public scorecard can help hold safety

AI can’t replace a physician’s gut feeling

Guardant Health colon cancer test endorsed by FDA advisory panel

knowledge

focus

explore

focus